International bonds: Biogen, 6.875% 1mar2018, USD
US09062XAB91

DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS

High performance interface for global bond market screening
Full information on close to 500,000 bonds from 180 countries
100% coverage of Eurobonds worldwide
Over 300 primary sources of prices
Ratings data from all international and local ratings agencies
Stock market data from 100 world trading floors
Intuitive, high speed user interface
Data access via the website, mobile application and add-in for Microsoft Excel

Files

Prospectus Supplement

Trading chart

Stock exchange selection

More about Cbonds Estimation

Bond is not traded; the issue is redeemed

Data display in a chart | table

Work with the chart: switching the price, period, issue comparison

Customize fields in the table

Found: {{ graphTablePointsTotal }}

Show all fields

* Data is not available within the selected subscription

Latest data on

Issue information

Profile

Biogen Inc. is a global biotechnology company. The Company discovers, develops, manufactures and markets therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. The Company’s products include AVONEX, TYSABRI, FAMPYRA, FUMADERM and RITUXAN.

Borrower

Go to the issuer page
Biogen
Full borrower / issuer name

Biogen Inc.
Sector

corporate
Industry

Healthсare
Stocks

Biogen, ordinary share
Biogen, depositary receipt
Biogen, depositary receipt

Volume

Placement amount

550,000,000 USD
Outstanding amount

550,000,000 USD

Nominal

Minimum Settlement Amount

2,000 USD
Outstanding face value

*** USD
Par amount, integral multiple

*** USD
Nominal

1,000 USD

Cash flow parameters

Reference rate

***
Coupon Rate

***
Day count fraction

***
Interest Accrual Date

***

Coupon frequency

*** time(s) per year
Payment currency

***
Delay days

*** days
Maturity date

***
Early redemption date

***

Cash flow

Calculations for international bonds are made according to the minimum trading lot

Early redemption terms

***

DATA PLATFORM FOR FINANCIAL MARKET PROFESSIONALS AND INVESTORS

High performance interface for global bond market screening
Full information on close to 500,000 bonds from 180 countries
100% coverage of Eurobonds worldwide
Over 300 primary sources of prices
Ratings data from all international and local ratings agencies
Stock market data from 100 world trading floors
Intuitive, high speed user interface
Data access via the website, mobile application and add-in for Microsoft Excel

Placement

Placement method

Open subscription
Placement type

Public
Order book

*** (***) - *** (***)
Coupon (Yield) Guidance

***% - ***% (*** - ***%)
Placement

*** - ***
Initial issue price (yield)

(***%)
Bids

*** USD
Number of bids

***
Geographic breakdown

***
Investor breakdown

***
Listing

***

Participants

Bookrunner

***, ***

Conversion and exchange

Convertion date

***
Initial premium

***%
Convertible until

***
Lock-up

*** days
Conversion terms

***

Additional information

***

Latest issues

Show all

News

11/06/2021	Moody's confirms Biogen at Baa1; stable outlook
05/11/2020	Biogen ( -/A -/ -) bonds are surging on positive news
29/04/2020	New bond issue: Biogen issued international bonds (US09062XAG88) with a 3.15% coupon for USD 1,500.0m maturing in 2050
29/04/2020	New bond issue: Biogen issued international bonds (US09062XAH61) with a 2.25% coupon for USD 1,500.0m maturing in 2030
11/09/2015	New bond issue: Biogen Idec sells USD 1,750.0m in 2025 bonds with a 4.05% coupon

All organization news

Identifiers

Registration

***
Date of program registration

***
ISIN

***
CUSIP

***
CUSIP 144A

***
CFI

DBFUGR
FIGI

BBG0000MW647
WKN

A0UK7Q
SEDOL

B2Q4667
Ticker

BIIB 6.875 03/01/18
Type of security by CBR

***

Show more Hide

Ratings

Do not show withdrawn ratings

Bond classification

Registered
Coupon bonds
Amortization
Callable
CDO
Convertible
Dual currency bonds
Floating rate
For qualified investors (CIS region)
Foreign bonds
Green bonds
Indexed
Supranational bond issues
Mortgage bonds
Perpetual
Payment-in-kind
Non-Marketable Securities
Redemption Linked
Restructuring
Retail bonds
Covered
Securitization
Structured product
Subordinated
Sukuk
Trace-eligible